Biopharmx Corp (BPMX) Short Interest Update
Biopharmx Corp (NYSE:BPMX) was the target of a significant increase in short interest in the month of September. As of September 29th, there was short interest totalling 4,147,107 shares, an increase of 2.1% from the September 15th total of 4,060,605 shares. Currently, 7.2% of the shares of the company are short sold. Based on an average trading volume of 1,362,369 shares, the days-to-cover ratio is presently 3.0 days.
Shares of Biopharmx Corp (BPMX) traded up 2.456% on Tuesday, hitting $0.292. 3,914,050 shares of the stock were exchanged. The firm’s 50 day moving average price is $0.30 and its 200 day moving average price is $0.46. The firm’s market cap is $23.26 million. Biopharmx Corp has a one year low of $0.19 and a one year high of $0.90.
Biopharmx Corp Company Profile
BioPharmX Corporation is a specialty pharmaceutical company. The Company is focused on utilizing its drug delivery technologies to develop and commercialize prescription and over-the-counter (OTC) products that address markets in women’s health and dermatology. Its portfolio of product candidates includes two clinical stage product candidates: BPX01, which is a topical antibiotic for the treatment of acne based on a formulation of minocycline, and BPX03, which is a molecular iodine (I2) tablet for the treatment of benign breast pain associated with fibrocystic breast condition (FBC) and cyclic mastalgia.
Receive News & Ratings for Biopharmx Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx Corp and related companies with MarketBeat.com's FREE daily email newsletter.